PharmacoEconomics & Outcomes News Weekly

, Volume 195, Issue 1, pp 10–10 | Cite as

Octreotide in carcinoid syndrome

worth the extra cost
Newsletter Article


Liver Metastasis Octreotide Vasoactive Intestinal Peptide Carcinoid Tumour Costly Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1999

Personalised recommendations